Disclosure Of Fair Value Measurement [Text Block]

Transgene - Filing #858281

Concept	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Disclosure of fair value measurement [text block]	—	—	ACTIFS FINANCIERS NON COURANTS	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets	66 436 EUR	—	—	—	—	—	—	—	—	—	—	101 838 EUR	—	—	—	—	—	—	—	—	—	—	—	—
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities	28 595 EUR	—	—	—	—	—	—	—	—	—	—	34 629 EUR	—	—	—	—	—	—	—	—	—	—	—	—
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity	—	50 628 EUR	—	32 804 EUR	808,000 EUR	450,000 EUR	70 813 EUR	50 102 EUR	37 841 EUR	19 536 EUR	2 933 EUR	—	31 092 EUR	1 423 EUR	67 209 EUR	67 441 EUR	48 886 EUR	50 716 EUR	41 921 EUR	1 051 EUR	17 231 EUR	13 861 EUR	1 726 EUR	39 212 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]